What is the recommended dose of Trimbow (formoterol, glycopyrronium, and beclometasone) in terms of puffs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

The standard recommended dose of Trimbow is two puffs twice daily, which means a total of four puffs per day. Typically, you should take two puffs in the morning and two puffs in the evening, with approximately 12 hours between doses. Trimbow is a triple combination inhaler containing beclometasone (an inhaled corticosteroid), formoterol (a long-acting beta-2 agonist), and glycopyrronium (a long-acting muscarinic antagonist), used to treat COPD or asthma. It's essential to use Trimbow regularly as prescribed, even when you're feeling well, as it helps control inflammation and prevent symptoms. After inhaling, rinse your mouth with water to prevent potential side effects like oral thrush. If you miss a dose, take it as soon as you remember, but don't double up if it's almost time for your next dose. Always follow your doctor's specific instructions, as they may adjust your dosage based on your individual condition and response to treatment, as seen in the study 1.

Some key points to consider when using Trimbow include:

  • The importance of regular use to control symptoms and prevent exacerbations
  • The need to rinse your mouth after inhalation to prevent side effects
  • The potential for dosage adjustments based on individual response to treatment
  • The use of Trimbow as part of a comprehensive treatment plan for COPD or asthma, as discussed in 2 and 3.

In terms of the evidence, the most recent and highest quality study 1 supports the use of Trimbow as a effective treatment for COPD, with improvements in lung function and reduction in exacerbations. This study, along with others 2, 4, 3, provides a strong foundation for the recommended dose of two puffs twice daily. It's also worth noting that older studies, such as 5, may not be directly relevant to the current recommended dose, but still provide valuable information on the safety and efficacy of the individual components of Trimbow.

Related Questions

What are examples of triple therapy inhalers for chronic obstructive pulmonary disease (COPD) and severe asthma?
Can Atrovent (ipratropium bromide) be added to a patient already receiving Trimbow (glycopyrronium/formoterol/budesonide)?
How should I use Breztri Aerosphere (beclomethasone dipropionate, formoterol fumarate, glycopyrronium bromide) as a twice‑daily maintenance inhaler for an adult with asthma or COPD?
Can tremors be a side effect of Breztri (budesonide, glycopyrrolate, and formoterol) in Chronic Obstructive Pulmonary Disease (COPD) patients?
Is the current inhaler regimen (beclometasone/formoterol 100 µg/6 µg twice daily plus tiotropium 18 µg once daily) optimal for a 73‑year‑old patient with emphysema who has a normal respiratory rate and oxygen saturation of 97 % according to UK guidelines?
What is the next step in managing a hypertensive (HTN) emergency that is not responding to nitroglycerin (NTG)?
What is the price comparison between intravenous (IV) 1 gram of acetaminophen and IV 1 milligram of hydromorphone?
What is the diagnosis for a patient with right lower back pain, given the presence of mild degenerative changes, ossific spurring, facet arthrosis, and mild degenerative disc disease in the lumbar spine, as seen on a lumbar spine X-ray (XR)?
What is the relationship between alveolar (air sacs in the lungs) radius and surface tension given that air can flow between alveoli (tiny air sacs in the lungs where gas exchange occurs)?
What is an arthropod-mediated hypersensitivity reaction?
What are the implications of elevated myeloperoxidase (MPO) antibody levels?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.